Main > HEMATOLOGY > USA. R. ITP Chronic>Treat.>SYK Inh>



USA. R. ITP Chronic>Treat.>SYK Inh>'s subsections
(*) CA Approval Date: 2020. 11.23
(*) EU Launch Date: 2020. 07.09.
(*) USA Approval Date: 2018. 04.17
(*) USA Launch Date: 2018. 05.29
>Tablets
Company
Company Licensee EU
Generic Name: Fostamatinib DiNa>
ITP: Immune Thrombocytopenia Purpur
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 11
Patent>UpDate: 2022. 01.04
RTM CA, USA
RTM CA, USA Web-Site
RTM EU
SYK: Spleen tYrosine Kinase

USA. R. ITP Chronic>Treat.>SYK Inh>'s products
This section has no products